Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 8, 2024
Total Value: $615M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 79,978 | $34.39M | 5.6% | $380.43 | — | SPONSORED ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 181,669 | $28.7M | 4.7% | $98.07 | +31.0% | COM | 803607100 |
| AXSM | AXSOME THERAPEUTICS INC | 337,246 | $27.15M | 4.4% | $69.19 | +7.0% | COM | 05464T104 |
| ASND | ASCENDIS PHARMA A/S | 186,581 | $25.45M | 4.1% | $127.91 | — | SPONSORED ADR | 04351P101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 703,398 | $24.05M | 3.9% | $29.91 | -12.3% | COM | 604749101 |
| — | INTRA-CELLULAR THERAPIES INC | 347,343 | $23.79M | 3.9% | $70.35 | — | COM | 46116X101 |
| VRTX | VERTEX PHARMACEUTICALS INC | 50,692 | $23.76M | 3.9% | $369.42 | +17.5% | COM | 92532F100 |
| INSM | INSMED INC | 323,360 | $21.67M | 3.5% | $38.78 | 0.0% | COM PAR $.01 | 457669307 |
| TMDX | TRANSMEDICS GROUP INC | 139,780 | $21.05M | 3.4% | $60.33 | +98.8% | COM | 89377M109 |
| KRYS | KRYSTAL BIOTECH INC | 109,222 | $20.06M | 3.3% | $110.89 | +51.4% | COM | 501147102 |
| — | BLUEPRINT MEDICINES CORP | 184,901 | $19.93M | 3.2% | $107.78 | — | COM | 09627Y109 |
| PCVX | VAXCYTE INC | 260,281 | $19.65M | 3.2% | $51.94 | +31.1% | COM | 92243G108 |
| NUVL | NUVALENT INC | 252,276 | $19.14M | 3.1% | $62.55 | +13.7% | COM | 670703107 |
| — | MERUS N V | 321,906 | $19.05M | 3.1% | $59.17 | — | COM | N5749R100 |
| ISRG | INTUITIVE SURGICAL INC | 41,901 | $18.64M | 3.0% | $398.28 | 0.0% | COM NEW | 46120E602 |
| IMVT | IMMUNOVANT INC | 695,428 | $18.36M | 3.0% | $34.61 | -17.8% | COM | 45258J102 |
| DXCM | DEXCOM INC | 160,096 | $18.15M | 3.0% | $102.16 | +23.8% | COM | 252131107 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 369,980 | $16.81M | 2.7% | $50.73 | 0.0% | COM | G31249108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 369,302 | $16.54M | 2.7% | $46.18 | 0.0% | COM | 22663K107 |
| CYTK | CYTOKINETICS INC | 293,318 | $15.89M | 2.6% | $36.21 | +66.7% | COM NEW | 23282W605 |
| ATEC | ALPHATEC HLDGS INC | 1,360,410 | $14.22M | 2.3% | $13.96 | -16.6% | COM NEW | 02081G201 |
| IDYA | IDEAYA BIOSCIENCES INC | 397,782 | $13.97M | 2.3% | $30.36 | +30.5% | COM | 45166A102 |
| XENE | XENON PHARMACEUTICALS INC | 339,876 | $13.25M | 2.2% | $35.33 | +13.1% | COM | 98420N105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 640,389 | $13.15M | 2.1% | $20.93 | 0.0% | COM | 87164F105 |
| RVMD | REVOLUTION MEDICINES INC | 329,519 | $12.79M | 2.1% | $37.38 | 0.0% | COM | 76155X100 |
| BHVN | BIOHAVEN LTD | 366,019 | $12.7M | 2.1% | $31.10 | +27.1% | COM | G1110E107 |
| APGE | APOGEE THERAPEUTICS INC | 318,327 | $12.53M | 2.0% | $43.66 | +11.2% | COM | 03770N101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,059,540 | $12.48M | 2.0% | $13.33 | -12.5% | COM | 483497103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 560,989 | $12.08M | 2.0% | $25.40 | -9.6% | COM | 77313F106 |
| SYRE | SPYRE THERAPEUTICS INC | 464,435 | $10.92M | 1.8% | $28.97 | +16.4% | COM NEW | 00773J202 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,515,960 | $10.72M | 1.7% | $11.07 | -19.1% | COM | 68622P109 |
| SLN | SILENCE THERAPEUTICS PLC | 537,338 | $10.21M | 1.7% | $19.00 | — | ADS | 82686Q101 |
| IMCR | IMMUNOCORE HLDGS PLC | 291,086 | $9.865M | 1.6% | $67.89 | — | ADS | 45258D105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 413,243 | $9.657M | 1.6% | $21.05 | 0.0% | COM | 29337E102 |
| VERA | VERA THERAPEUTICS INC | 212,944 | $7.704M | 1.3% | $37.43 | +6.0% | CL A | 92337R101 |
| IRON | DISC MEDICINE INC | 138,907 | $6.261M | 1.0% | $56.35 | -39.7% | COM | 254604101 |